Literature DB >> 18533953

Characteristics of primary vesico-ureteral reflux in Thai children.

Prayong Vachvanichsanong1, Pornsak Dissaneewate, Apiradee Lim.   

Abstract

BACKGROUND: The purpose of the present paper was to evaluate the clinical features of primary vesico-ureteral reflux (VUR) in Thai children.
METHODS: Children with primary VUR attending in the Nephrology Division, Department of Pediatrics, Prince of Songkla University between 1987-2002 were studied.
RESULTS: Sixty-five girls and 60 boys with primary VUR were evaluated. Age of diagnosis was significantly younger in boys than girls (median 0.6 and 2.2 years respectively, P < 0.001). In 73% of boys and 34% of girls VUR diagnosis was made in the first year of life. Hydronephrosis was found in 22% of boys and 8% of girls (P = 0.004). Five per cent of children who had VUR grades I-III had hydronephrosis (6/121). Only children who had VUR grades IV and V had significant hydronephrosis: 33% (14/42) and 53% (10/19), respectively. Bilateral VUR was 60% overall and was significantly more common in boys (70% vs 40% P < 0.028), found in grades I-V at 33%, 61%, 60%, 65%, and 77%, respectively. Of 200 refluxing ureters, the total numbers of VUR grades I-V were 32, 37, 67, 45 and 19 respectively. VUR grade was significantly different by age (P = 0.014) but not by left-right side or sex.
CONCLUSION: Primary VUR occurs equally in boys and girls, but in boys at a younger age. Bilateral VUR and hydronephrosis were significantly more common in boys, and VUR in boys was more severe. But hydronephrosis is a poor indicator for VUR screening even in high-grade VUR.

Entities:  

Mesh:

Year:  2008        PMID: 18533953     DOI: 10.1111/j.1442-200X.2008.02594.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  1 in total

1.  Outcome of vesicoureteral reflux in infants: impact of prenatal diagnosis.

Authors:  Hamid Mohammadjafari; Alireza Alam; Saeed Mohammadi; Seyed-Abdollah Mousavi; Ahmadshahab Kosaryan; Mohammad Khademloo; Mohammad Abedi
Journal:  Iran J Pediatr       Date:  2013-08       Impact factor: 0.364

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.